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Alterations in DNA methylation have been implicated in mammalian development. Hence, the identification of tissue-specific differentially
methylated regions (TDMs) is indispensable for understanding its role. Using restriction landmark genomic scanning of six mouse tissues, 150
putative TDMs were identified and 14 were further analyzed. The DNA sequences of the 14 mouse TDMs are analyzed in this study. Six of the
human homologous regions show TDMs to both mouse and human and genes in five of these regions have conserved tissue-specific expression:
preferential expression in testis. A TDM, DDX4, is further analyzed in nine testis tissues. An increase in methylation of the promoter region is
significantly associated with a marked reduction of the gene expression and defects in spermatogenesis, suggesting that hypomethylation of the
DDX4 promoter region regulates DDX4 gene expression in spermatogenic cells. Our results indicate that some genomic regions with tissue-
specific methylation and expression are conserved between mouse and human and suggest that DNA methylation may have an important role in
regulating differentiation and tissue-/cell-specific gene expression of some genes.
© 2006 Elsevier Inc. All rights reserved.Keywords: DNA methylation; Tissues; CpG islands; Bisulfites; DDX4; Gene expression; Testis; Spermatocytes; Gene expression regulation; Human genomeIntroduction
DNA methylation of cytosine at position C5 in CpG
dinucleotides in the mammalian genome is an inheritable
modification of DNA that does not alter the nucleotide sequence
[1,2]. It is important to understand the global genome-wide
DNA methylation patterns and to understand the role of
methylation in diverse genomic processes such as chromosomal
stability, gene regulation, and parental imprinting. Many of
these processes and their relationship to genome-wide methyl-⁎ Corresponding author. Life Science, Advanced Research Institute for the
Sciences and Humanities, Cancer Genetics, Nihon University School of
Medicine, 30-1 Oyaguchi, Kami-cho, Itabashi-ku, Tokyo 173-8610, Japan.
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doi:10.1016/j.ygeno.2006.11.006ation patterns are still unknown. This is partly due to a lack of
high-throughput methods for scanning quantitative changes in
DNA methylation status at each CpG dinucleotide in the
genome. Generally, cytosine residues in the CpGs are
methylated in the genome, especially within noncoding DNA,
introns, repetitive sequences, and potentially active transpos-
able elements resulting in long-term silencing [3,4]. Most CpG
clusters, called CpG islands, frequently found in the proximal
promoter regions of many genes, are unmethylated during
normal cell development, with the exception of imprinted
genes, genes on the inactive x chromosome, and tissue-specific
differentially methylated genes [1,5–7]. Studies indicate that
aberrant DNA methylation patterns of gene promoters impair
normal transcription, causing abnormal development associated
with various diseases such as cancer [8–11].
Table 1
Conserved regions of TDMs in human
TDM loci identified in mice Human orthologues
Mouse
loci a
UCSC location
(August 2005) (Mb) b
NotI site
location
CpG
island
Gene Human
loci
UCSC location
(March 2006) (Mb) b
Homologous
region
CpG
island
Gene Function
Pvu2 chr11:115.57 Exon 2 No AK037416 hPvu2 chr17:70.60 Exon 5 No SLC16A5 Solute carrier family 16 (monocarboxylic
acid transporters), member 5
Pvu4 chr7:11,55 Exon 4 cpgi 32 zfp324 hPvu4-1 chr19:63.67 Exon 4 cpgi 109 ZNF324 Zinc finger protein 324
hPvu4-2 chr19:63.66 Exon 4 cpgi 84 ZNF324B Hypothetical protein LOC388569
Pvu6 chr17:45.80 Exon3 c Close to
cpgi 56
Usp49 hPvu6 chr6:41.88 Exon 4 Close to
cpgi 46
USP49 Ubiquitin-specific peptidase 49
Pvu8 chr4:59.04 5′ Promoter cpgi 76 AK136359 hPvu8 chr9:113.43 5′ Promoter cpgi 89 bA16L21.2.1 DnaJ-like protein (predicted gene)
Pvu29 chr14:51.53 5′ Promoter cpgi 65 4930548G07Rik hPvu29 chr13:19.10 5′ Promoter cpgi 71 HSMPP8 M-phase phosphoprotein, mpp8
Pvu42 chr1:16.80 5′ Promoter cpgi 107 6130401J04Rik hPvu42 chr8:74.95 5′ Promoter cpgi 109 UBE2W Ubiquitin-conjugating enzyme E2W
Pvu66 chr11:43.73 Exon 2 cpgi 46 Adra1b hPvu66 chr5:159.33 Exon 2 cpgi 95 ADRA1B Andrenergic receptor, α 1b
Pst3 chr13:109.80 Exon 1 cpgi 68 Ddx4 hPst3 chr5:55.06 5′ Promoter cpgi 30 DDX4 DEAD box polypeptide 4, RNA helicase
Pst6 chr17:33.07 Exon 2 cpgi 33 Hspa1l hPst6 chr6:31.88 Exon 2 No HSPA1L Heat shock 70-kDa protein 1-like
Pst32 chr12:69.26 Exon 4 cpgi 74 Dact1 hPst32 chr14:58.18 Exon 4 Close to
cpgi 50
DACT1 Dapper, antagonist of β-catenin,
homologue 1
Pst33 chr7:41.96 Exons No Lmtk3 hPst33 chr19:53.69 Exon 12 Close to
cpgi 93
LMTK3 Lemur tyrosine kinase 3
Pst61 chr6:88.26 5′ Promoter cpgi 101 Gata2 hPst61 chr3:129.69 5′ Promoter cpgi 514 GATA2 GATA-binding protein 2
Pst21 chr19:6.40 Intron No Nrxn2 hPst21 chr11:64.15 Intron No NRXN2 Neurexin 2 isoforms
Pst46 chr17:17.10 No c No No c Not
conserved
a Locus names are quoted from Song et al. [23].
b The BLAT, UCSC Genome Bioinformatics website was used for the search.
c The differences between the October 2003 assembly and the August 2005 assembly at the University of California, Santa Cruz, Bioinformatics Database.
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328 E. Kitamura et al. / Genomics 89 (2007) 326–337A comparative genomic approach is valuable for studying
the role of transcriptional regulation in diverse biological
processes. Several studies suggest that epigenetic modifica-
tions including DNA methylation are conserved between
mouse and human. Histone modifications between human and
mouse are strongly conserved even though many histone H3
lysine 4 methylated sites do not show sequence conservation[12]. The H3 lysine 4 methylation is associated with
chromatin remodeling through the plant homeodomain finger
proteins [13,14]. Evolutionary conservation of tissue-specific
methylation in human tissue was recently identified among
brain, keratinocytes, and peripheral blood lymphocytes by a
genome-wide epigenome analysis using BAC microarrays.
These studies indicated that the tissue-specific methylation
pattern of the SHANK3 gene was conserved in human, mice,
and rats, whereas the Arhgef17 was not [15]. Although several
human genome-wide methylation studies have been published
[16–19], comparative approaches were also successfully
applied for identification of human epigenetic alterations
using mouse models for human cancers and mammalian
development [20–22]. One of the major problems of the
genome-wide approach in the human genome is a high
frequency of sequence polymorphisms in the population [15].
However, a comparative approach that first identifies tissue-
specific differentially methylated regions (TDMs) in inbred
mice will help to identify evolutionary conserved human
TDMs and critical genes that are methylated during develop-
ment and therefore avoid the problem of single-nucleotide
polymorphisms in humans.
Recently, 150 TDMs were predicted among tissues of
C57BL/6J mice using restriction landmark genomic scanning
(RLGS) in conjunction with virtual RLGS [23]. These results
suggest that at least 5% of 15,500 CpG islands in the mouse are
differentially methylated. In that study, 14 mouse TDMs were
further analyzed by methylation-specific PCR and by bisulfite
genomic sequencing to confirm that the regions identified by
RLGS are differentially methylated in a tissue-specific manner.
These studies also indicated that the TDMs within CpG island
5′ promoter regions correlate to tissue-specific gene expression
patterns [23].Fig. 1. Analysis of a human homologous region, hPvu6, and the corresponding
human gene, USP49, which is associated with the conserved region. (A)
Chromosomal location of hPvu6. An asterisk represents the position of hPvu6,
which corresponds to the mouse NotI site within the mouse TDM, Pvu6 (see
Materials and methods). The sequence of the conserved NotI site in humans is
shown in boldface type. This map is based on UCSC Genome Browser on
Human, March 2006 Assembly (http://genome.ucsc.edu). The scale is
represented below the diagram in basepairs. The gene is shown as solid bars
with an arrowhead indicating the orientation of USP49. CpG islands (cpgi) are
shown with the number of CpGs within the CpG island sequence. The
restriction map of the region including the conserved NotI site is indicated with
a solid bar that represents the probe used for Southern hybridization. The
sequence of the conserved NotI site in humans is shown in boldface type. (B)
Southern blot analysis. Genomic DNAs were prepared from testis, muscle,
kidney, heart, and colon of sample 102 and digested with methylation-sensitive
enzyme NotI and methylation-insensitive enzyme EcoRI. (C) Bisulfite genomic
sequence of the homologous region including the NotI site. Arrowheads
indicate CpGs within the NotI site. The primer pair USP49-3F and-3R was
used for bisulfite sequencing (Table 3). More than 10 clones of each single
bisulfite-treated DNA from four tissues were subjected to sequence analysis.
Black and white circles represent methylated and unmethylated CpGs,
respectively. N means undetectable. (D) Bisulfite sequence of cpgi 46, which
is adjacent to the conserved NotI. The fragments were amplified by the primer
pair USP49-F and-R. Two samples, 102 and 108, were employed for this
experiment. Black and white circles represent methylated and unmethylated
CpGs, respectively. N means undetectable.
329E. Kitamura et al. / Genomics 89 (2007) 326–337Here we describe the analysis of the human genomic regions
homologous to the 14 confirmed TDMs found in the C57BL/6J
mouse to investigate whether tissue-specific methylation is
conserved in human. The expression of genes located nearby or
overlapping with the homologous regions of the mouse TDMs
were analyzed to assess whether the expression is associated
with methylation patterns of the human homologous region.
Results
Searching for human conserved regions of mouse TDMs
We searched for the human orthologues of the 14 TDMs
identified in mice [23] using the Human March 2006 (hg18)
assembly, UCSC Genome Bioinformatics browser. The DNA
sequences of 13 of the 14 confirmed mouse TDMs are conserved
in the human genome and are located near homologous human
genes. One TDM on mouse chromosome 17 (Pst46) is not
conserved (Table 1), but the mouse TDM sequence overlaps a
long terminal repeat (LTR) (96.65% similarity of ERV class II
LTR sequence by RepeatMasker version open-3.1.5) (Smit,
A.F.A., Hubley, R., and Green, P. RepeatMasker Open-3.0.
1996–2004 http://www.repeatmasker.org). One of 13 con-
served loci is duplicated in the human genome: one within the
ZNF324 gene and another within the ZNF324B(FLJ45850)
gene (94% identities).
Interestingly, the NotI sites, which were used for RLGS as a
restriction landmark in the mouse, are conserved in two human
homologous regions, one on chromosome 6 (hPvu6) and the
other on chromosome 5 (hPvu66), located within theUSP49 and
ADRA1B genes, respectively (Table 1). To examine theTable 2
Hypomethylation level of CpGs determined by bisulfite sequencing
A. Sample 102
Loci Gene Examined region Hypom
Testis
hPst3 DDX4 5′ cpgi 30 0.9
hPst32 DACT1 Close to cpgi 50 in exon 1.5
hPvu4-1 ZNF324 cpgi 109 in exon 1.6
hPvu4-2 ZNF324B cpgi 84 in exon 1.8
hPvu6 USP49 Close to cpgi 46 in exon 1.3
hPst6 HSPA1L Coding region 0
hPvu2 SLC16A5 Coding region 0
hPst33 LMTK3 Close to cpgi 93 in exon 0.5
hPvu42 UBE2W 5′ cpgi 109 1.9
hPvu8 bA16L21.2.1 5′ cpgi 89 1.9
hPvu29 HSMPP8 5′ cpgi 71 2.0
B. Sample 114
Loci Gene Examined region Hypom
Testis
hPst21 NRXN2 Intron region 0.1
hPvu66 ADRA1B cpgi 95 in exon 1.7
hPst61 GATA2 5′ cpgi 514 1.8
Note. Underlined genes are hypomethylated in testis only.
a Hypothylation level is estimated as 2 when it occurs 100% unmethylated in dipmethylation status of the NotI site in human, Southern blot
analysis was carried out for the hPvu6 region, using one of two
autopsy cases (Fig. 1A). For this experiment, EcoRI and NotI
were employed as methylation-insensitive and methylation-
sensitive enzymes, respectively. A Southern blot of a double
digestion with EcoRI and NotI produced a single 8-kb band
signal observed in colon, heart, kidney, and muscle tissues,
indicating that the NotI site is completely methylated in these
tissues (Fig. 1B). On the other hand, two bands signals, 8 and
5 kb in length, were detected in testis. The methylation state of
the testis sample was estimated by the signal intensity of the
Southern blot bands. According to the (P − B)/mm2 values, the
(P − B)/mm2 value of the 5-kb band is 2.84 and that of the 8-kb
band is 2.12 as measured by FLA5100; 57% of the NotI site was
unmethylated (2.82/(2.84+2.12)×100=57). This reflects either
cell or allelic heterogeneity in tissue materials. Bisulfite
sequencing of the region was performed using the same sample
to confirm the methylation level of the NotI site (Fig. 1C). There
are nine CpGs in the 182-bp fragments and two of them are
located within the NotI site. The two CpGs are methylated in
kidney, heart, and colon. In contrast, they are unmethylated in 7
of 12 clones in testis, indicating 58% hypomethylation in testis.
This confirms that the region containing the NotI site is a TDM
in humans. According to UCSC Genome Bioinformatics, there
is a predicted cpgi 46 in the vicinity of hPvu6 (Fig. 1A). We
therefore analyzed the methylation pattern of cpgi 46 by bisulfite
sequencing to see whether the CpG island is also differentially
methylated. Both autopsy cases examined indicate that this
region is largely hypomethylated in testis (Fig. 1D). Thus, the
sequence homologous to the mouse Pvu6 is also a TDM in
human.ethylated CpGa
Muscle Kidney Colon Heart Brain
0.1 0 0 0.1 0.1
0.2 0 0.1 0 0
0.1 0.1 0.1 0.1 0.1
0 0 0.1 0 0
0.1 0.1 0 0.1 0
0.1 0 0 0.1 0
0 0 0 0 0
0 0.1 0.1 0 0
2.0 2.0 2.0 2.0 2.0
2.0 2.0 2.0 2.0 2.0
2.0 2.0 2.0 2.0 2.0
ethylated CpG a
Muscle Kidney Colon Liver Brain
0.1 0.2 0.1 0.1 0.6
1.4 1.3 1.5 1.0 0.9
1.9 1.3 1.8 1.9 1.8
loids.
330 E. Kitamura et al. / Genomics 89 (2007) 326–337Analysis of human TDMs by bisulfite sequencing
Since we obtained a good correlation between the Southern
blot results and bisulfite sequencing of hPvu6, we carried
out bisulfite sequencing on the remaining 12 conserved
regions to confirm the methylation patterns (see Supplemen-
tary Figures). For this experiment, we used two autopsy cases,
102 or 114, depending on the availability of tissue. The results
are summarized in Table 2. For example, the bisulfite se-
quencing of hPst3 using case 102 is shown in Fig. 2. Five of
the human homologues to mouse TDMs (hPvu6, hPst3, hPvu4-
1, hPvu4-2, and hPst32) are primarily hypomethylated in
human testis, the same pattern as observed in the mouse (Figs.
1 and 2, Supplementary Figs. S2 and S8). In addition, testis-
specific hypomethylation was observed in cpgi 93, which is
located in the vicinity of hPst33. The human homologous
region of Pst33 itself is outside of the CpG island (cpgi 93) and
methylated in all six tissues examined (Supplementary Fig. S9).
In contrast to their mouse orthologues, five of the human loci
do not exhibit tissue-specific differences in methylationFig. 2. Bisulfite sequencing of hPst3. (A) Chromosomal location of hPst3 and DD
Assembly (http://genome.ucsc.edu). The scale is represented below the diagram in bas
of the gene. CpG islands are shown with the number of CpGs. The position corresp
sequence corresponding to the NotI site determined by RLGS in mouse is shown in u
CpG island is 299 bp in size and is located at the promoter of DDX4. Arrowheads poin
each sample. Black and white circles represent methylated and unmethylated CpGs,(hPvu2, hPvu8, hPvu29, hPvu42, and hPst6) (Supplementary
Figs. S1, S3−S5, and S7). Another autopsy case, 114, for
which liver was available, was employed for the analysis of
hPvu66, hPst61, and hPst21, since the corresponding loci in
mice revealed either liver-specific methylation or hypomethy-
lation [23]. Although there are some apparent differences in
tissue-specific methylation, none of these loci had liver-specific
differences in methylation as was observed in the mouse [23]
(Supplementary Figs. S6, S10, and S11).
Expression analysis of genes
To determine whether the gene expression pattern is asso-
ciated with the methylation patterns, we prepared RNA from the
same tissue samples used in the bisulfite sequencing and
analyzed the mRNA levels by quantitative RT-PCR (Fig. 3). The
genes DDX4, DACT1, ZNF324, and ZNF324B(FLJ45850)
associated with TDMs (hPst3, hPst32, hPvu4-1, and hPvu4-2)
that were unmethylated only in testis showed a notably high
level of expression in testis and no or a low level of expression inX4. This map is based on UCSC Genome Browser on Human, March 2006
epairs.DDX4 is shown as solid bars with an arrowhead indicating the orientation
onding to mouse NotI included in hPst3 is indicated as an asterisk. The human
ppercase characters. (B) Bisulfite genomic sequence of cpgi 30 in case 102. The
t to the CpG at hPst3 underlined above. More than 10 clones were sequenced for
respectively. N means undetectable or polymorphisms.
Fig. 3. Gene expression. Quantitative real-time PCR was performed to measure the mRNA expression of genes. Samples 102 and 114 were used for A and B,
respectively. Yaxis represents normalized quantity determined by the standard curve of each gene. The expression value was calculated as themean of three independent
quantitative RT-PCR data. Error bars indicate± the standard deviation of the mean. No asterisk, Y axis scale is 100; *, Y axis scale is 10; **, Y axis scale is 0.5.
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332 E. Kitamura et al. / Genomics 89 (2007) 326–337other tissues (Fig. 3A). There is a relative testis-specific
expression of USP49 and some expression of LMTK3 in testis,
though the expression levels are low (Fig. 3A). These results
indicate that some of the hTDMs that were unmethylated only in
testis had testis-specific expression. Some genes were expressed
in a tissue-specific fashion even though we did not detect tissue-
specific methylation. HSPA1L is known for exclusive expres-
sion in testis as shown in Fig. 3A. SLC16A5 and GATA2 show a
high level of expression in kidney (Figs. 3A and B). LMTK3 and
NRXN2 are expressed at a relatively high level in brain
compared to other tissues (Fig. 3B). HSMPP8, bA16L21.2.1,
and UBE2E are highly expressed in testis in the samples
examined (Fig. 3A). However, in these cases there is no clear
relationship between the expression of these genes and
methylation patterns of the conserved regions (Fig. 3A,
Supplementary Figs. S3–S5).
The association of methylation patterns of DDX4 with
pathological findings in human testis
We have shown that hypomethylation of the DDX4 CpG
island promoter region (hPst3) is associated with testis-specific
expression (Figs. 2 and 3). To characterize the effect of
methylation changes on DDX4 expression in humans, a total of
nine testis samples (four samples from individuals in which
histology indicated no or a low spermatocyte count, two from a
moderate spermatocyte count, and three from a relatively high
spermatocyte count) were examined. Figs. 4A and B show three
representative histological and corresponding methylation
patterns. We could not measure the DDX4 expression level in
one of the cases, 106, because of RNA degradation. DDX4
expression has a significant linear correlation with the number
of spermatocytes of eight testes (P=0.0002) and an inverse
linear correlation with cpgi 30 methylation (P=0.0248) (Figs.
4C and D). There was an inverse correlation between promoter
methylation and gene expression. An increase in methylation ofthe TDM region is accompanied by suppression of gene
expression and spermatogenesis. Thus, DDX4 expression is
clearly important to the production of spermatocytes.
Discussion
In this report, we show that the nucleotide sequences of most
confirmed mouse TDMs (13 of 14) are conserved in human.
However the tissue-specific methylation of these regions is
conserved in only a subset of TDMs (hPst3, hPst32, hPvu4, and
hPvu6). These regions are hypomethylated in testis and
methylated in all other tissues tested in both mouse and
human. Importantly, the genes associated with these regions
(DDX4, DACT1, ZNF324/ZNF324B(FLJ45850), and USP49)
exhibit testis-specific expression. However, the tissue-specific
methylation of several other mouse TDMs does not appear to be
conserved in human. The methylation patterns of three mouse
TDMs that are methylated (Pst21) or unmethylated (Pvu66,
Pst61) in liver are not conserved and not correlated with gene
expression in human. Currently, we do not know whether this
reflects differences between tissues and/or whether there are
additional functional consequences of tissue-specific methyl-
ation. Some of the genes associated with TDMs exhibited
testis-specific expression in humans even though the ortholo-
gues were not hypomethylated exclusively in testis (HSPA1L,
bA16L21.2.1, HSMPP8, and UBE2W). The precise boundaries
of the TDMs have not been clearly defined in either mouse or
human. Thus, the region identified in mouse may not be the
critical region for determining testis-specific expression. For
examples, the hPst33 within the LMTK3 gene was methylated
in all tissues examined but the LMTK3 cpgi93 was a TDM in
humans (Supplementary Fig. S9). The number of methylated
clones of hPvu4-1 and hPvu4-2 (Supplementary Fig. 2) is also
much higher than those in the downstream regions examined
for CpG islands within the ZNF324 and ZNF324B(FLJ45850)
genes in testis. It also appears likely that promoter methylation
333E. Kitamura et al. / Genomics 89 (2007) 326–337is not the only determinant for tissue-specific expression, as
seen in exonic methylation of PAX6 and hypomethylation of
the Tact1/Actl7b genes, which associate with specific gene
expression in cancer and testis, respectively [24,25]. Moreover,
hypomethylation of the promoter CpG island regions may be
necessary but not sufficient for expression.
We identified 5 TDMs in human that correlated with gene
expression patterns, providing further evidence that human geneFig. 4. Association of methylation status of the DDX4 promoter region with the gene e
(×400) from three autopsy cases, 114, 106, and 130. Case 114 represents preserved sp
in case 130. (B) DDX4 promoter methylation levels from three cases: 114, 106, and
level (Y axis) from eight autopsy cases. (D) A scatter plot of percentage methylatio
expression analysis was performed in triplicate and standard error is indicated as Y-expression could be regulated by DNA methylation-mediated
gene silencing. Analysis of the other 136 mouse TDMs predicted
byRLGS [23]will allow us to identify additional unknown tissue-
specific expressing genes regulated by DNA methylation in
humans. Human TDM regions are located within exons of the
four genes DACT1, ZNF324B(FLJ45850), ZNF324, and USP49
and their methylation-repressed gene expressions. Although we
have not analyzed promoter methylation of those genes,xpression and pathological findings in testis samples. (A) H&E sections of testis
ermatogenesis, case 106 shows maturation arrest, and only Sertoli cells are seen
130. (C) A scatter plot of the number of spermatocytes (X axis) and expression
n (X axis) and expression level (Y axis) from eight autopsy cases. Quantitative
axis error bars.
Fig. 4 (continued ).
334 E. Kitamura et al. / Genomics 89 (2007) 326–337intragenic DNA methylation is known to be capable of altering
chromatin structure and elongation efficiency in mammalian cells
depleting RNA polymerase II exclusively in the methylated
region [26]. By searching the sequence database (Repeat Masker
program), someAlu elementswere foundwithin 2 kb downstream
or upstream of some TDMs. It has been suggested that
methylation of Alu elements could suppress transcription and
contribute to differential expression of genes [27–29]. A mouse
TDM, Pst46, that was not conserved in human was located within
the endogenous retrovirus LTR sequence in the mouse. A study of
transgenic mice demonstrated that epigenetic modification of
transgenes under the control of the mouse mammary tumor virus
LTR conferred a tissue-dependent influence on transcription of
the transgenes [30]. Endogenous LTR sequences may be
differentially methylated as seen in mouse Pst46, the LTR
transgene, and human repeat sequences. Thus, repeat sequences
flanking each TDM might be involved with gene silencing,
though its mechanism remains to be elucidated.
HSPA1L encodes a 70-kDa heat shock protein and is located
in the major histocompatibility complex class III region [31].
There is a duplicated gene, HSPA1A, located 4 kb downstream
of HSPA1L. It is well known that HSPA1L RNA expression is
restricted to testis (Fig. 3) [32,33]. The RNA expression of
HSPA1A is significantly different from that of HSPA1L,
showing a variable level of expression in several tissues
[33]. The bisulfite sequencing of the conserved region, hPst6,
which is within the coding sequence of HSPA1L, showed
hypermethylation in all tissues we examined (Supplementary
Fig. S7). We also analyzed a CpG island that is localized at the
5′ region of HSPA1L and also overlaps with the duplicated
gene, HSPA1A. The CpG island is hypomethylated (Supple-
mentary Fig. S7), indicating that neither the conserved region
nor the CpG island is associated with the RNA expression of
HSPA1L. In contrast, other duplicated genes, ZNF324 and
ZNF324B(FLJ45850), for hPvu4 have CpG islands in the
coding regions, respectively (Supplementary Fig. S2). BothCpG islands for hPvu4 are hypomethylated in testis and
hypermethylated in other tissues and the expression of both
genes is associated with the hypomethylation pattern (Supple-
mentary Fig. S2). It is of interest that both genome duplication
events in human evolution are not found in the chimpanzee
(Pan troglodytes) genome and that transcriptional regulation
associated with DNA methylation was conserved in one at
hPvu4, but not the other at hPst6 and cpgi185.
Another five genes (HSPA1L, SLC16A5, UBE2W, bA16L21.2.1,
and HSMPP8) have no obvious TDMs within the conserved
regions although the genes are expressed in a tissue-specific
manner. Although additional tissues from young individuals
should be analyzed, the expression of these genes may be
regulated by some transcriptional factors or cis elements, but not
by DNA methylation-mediated gene silencing, at least in the
individuals examined. Alternatively, we may not have identified
the critical region required for tissue-specific methylation and
expression. Various patterns of tissue-specific differential meth-
ylation are also observed in three genes, ADRA1B, GATA2, and
NRXN2, showing small differences in methylation (Supplemen-
tary Figs. S6, S10, and S11). The TDM patterns of these genes
have some similarity between human and mouse, but are not
completely the same. This might be attributed to the lack of
identification and bisulfite sequence analysis of the critical target
region of the TDMs, the mixture of various cell types in samples,
the age effect of the cell population in humans, or simply the
difference between species. Analysis of characterized cells iso-
lated from the tissues of various ages would be informative for
understanding the mechanism of DNA methylation-mediated
gene silencing of these genes.
DDX4 (also called VASA) is an RNA helicase, an essential
enzyme involved in RNA metabolism and well known as a
specific marker for germ cells [34]. The knockout of Ddx4 in
mice results in infertility in males although primordial germ
cells do form, suggesting an essential role in spermatogenesis
but not in germ cell development [35]. Recent studies show that
Ddx4/MVH interacts with Dicer and components of the
microRNA-processing body in chromatoid bodies [36]. Ddx4
also interacts with a protein involved in microtubule nucleation,
suggesting a functional relationship between translational
control of Ddx4 and microtubule nucleation, which occurs
during meiosis [37]. Castrillon et al. [38] has reported that the
DDX4 protein is expressed in cells within the seminiferous
tubules. The expression is low in spermatogonia and high in
spermatocytes. As seen in mice, the CpG island promoter region
of the DDX4 gene was hypomethylated in human testis. We also
demonstrated the association of DDX4 expression and sper-
matogenesis in addition to the association of the promoter
methylation and DDX4 expression, suggesting promoter
hypomethylation of DDX4, and possibly other testis-specific
expressed genes may play an important role in initiating the
spermatogenesis process in testis. However, at this time we
cannot determine whether hypomethylation is causally linked to
spermatogenesis or is a consequence of spermatogenesis. It is
also important that DNA methylation at TDMs is associated
with gene expression in a specific cell population during the
spermatogenesis process, confirming the previous hypothesis
Table 3
Primers used for bisulfite sequencing and quantitative RT-PCR
Gene Primer name Sequence (5′–3′) Product size (bp)
Bisulfite sequence
DDX4 DDX4-F GTTTTGTATTTATAGGTTTAATAGGTTATT
DDX4-R CATCCACACTTTAACCAAAAATC 368
HSPA1L HSPA1L.c-F TGGTTAGAATTGATATATTAAATGTG
HSPA1L.c-R ATAAAACTTTCTACCCTAAAAAAATC 303
hHSPA1L-F GATTTGGGTATTATTTATTTTTG
hHSPA1L-R TCACCTACACCTTAAACTTATCTCC 289
DACT1 DACT1.50-2F GGAAGAGAGGTTTGTTTTGGATTTTA
DACT1.50-2R CTCTTCCTCCCCTTAAAAAAAACTTT 306
GATA2 GATA2-4F TTTGGAGTAGAGTTGGGAGTAGG
GATA2-4R ACATCCATCCTAACAAAACCC 175
NRXN2 NRXN2.int-F TTATGGAGGAATAAGTATTGGTG
NRXN2.int-R ATTCCCCAATTACCTCATTAAAC 381
LMTK3 LMTK3.93-5F GGTTGTTAGGTAGGTGTTTTTTTAT
LMTK3.93-5R CCCTAACCCCCTACACACAATA 197
LMTK3.93-8F GAGTAAGTAGGTGAGTTGTAAT
LMTK3.93-9R AAATCTCTATTACCCTCTAAATCTC 204
ZNF324 ZNF324.109-3F GTGGATTGTGGTAAGGTTTT
ZNF324.109-3R CCTTATCCCTAACTAACAAACAC 411
ZNF324B(FLJ45850) FLJ45850.84-F GGTGTTGTTTTTAGTTAGGGTTTTT
FLJ45850.84-R AACTAAACTTAACTTCCCTCCCC 408
USP49 USP49-3F TTTTTTAGTAGTTTTAGGTTTTTTTTT
USP49-3R ACCTACCTCAAATACTCCCAC 182
USP49-F GTTGAGTATTTGGAGGATGGAGTTTAT
USP49-R CTAAAAAAACTAACCAACACCCCTC 228
UBE2W FLJ11011-6F GGGGGTAAAGGTAATTTTGG
FLJ11011-6R CCTATTTTCCCTCAACTCAAA 239
SLC16A5 SLC16A5.c-F TGTGTTTTAGTTTTTAGTTAAGTATT
SLC16A5.c-R ACCAAACAACCAAATACAAATATC 298
HSMPP8 HSMPP8-F TGATTGGTTTTTGTTTTTGTTATTTTAGG
HSMPP8-R ATCTTCATATCCAAAATCTTCTCCACC 363
ADRA1B ADRA1B-3F TTTATGTTTTAGTAAGGAGTTTAAG
ADRA1B-3R CCAAAAACATATTACTTTTAAAACC 503
bA16L21.2.1 BC048318-4F GAAGGAAGTAGTTGTTGTAGT
BC048318-4R TAAAACCCCTCCACCAAAAC 279
qPCR
GAPDH GAPDH-F GAAGGTGAAGGTCGGAGTC
GAPDH-R GAAGATGGTGATGGGATTTC 226
DDX4 DDX4.RT-2F TGGATGATGGACCTTCTCGAA
DDX4.RT-2R CTCGCTTATTACACTCACCAGCAT 99
DACT1 DACT1.RT-2F GCTGCTAAGAAAGCAATTGAACTG
DACT1.RT-2R AGGTCACTTATCTGCTTGTCAAGCT 90
HSPA1L HSPA1L.RT-2F CGGTTGTGCAGTTTGATATTGAG
HSPA1L.RT-2R CGATGCCTATGGCGATTCC 144
GATA2 GATA2.RT-2F CATCAAGCCCAAGCGAAGA
GATA2.RT-2R GTCCCCGTTGGCGTTTC 106
NRXN2 NRXN2a1.2.RT-2F AGCGAAGTAGGGTCCTTACTGTTC
NRXN2a1.2.RT-2R CAAACTCCTCCTTGCCTTTTGT 94
LMTK3 LMTK3.RT-4F GCAAGTTCATCTCGGAAGCACA
LMTK3.RT-4R GGCTCGGAGGTAACGCTTCA 146
ZNF324 ZNF324.RT-3F CCTGTGAGATGGCTCTGTGG
ZNF324.RT-3R TAGCTCTGTCCTTCCAATGCTG 150
ZNF324B(FLJ45850) FLJ45850-3F GAGGAATGCCCATGGTTCTC
FLJ45850-3R CAGGTGTAAAGGCTCCTCCTC 155
USP49 USP49.RT-F CTCATCCCCTTCTCCCAGAG
USP49.RT-R TTCCAGGGATAGGTCCCAAA 150
UBE2W FLJ11011.RT-2F GGCCTCGCCGGTCTTG
FLJ11011.RT-2R CATTCCAGGAGGTGGGTCAT 101
SLC16A5 HA012354-F GCCCTGCTTGAGTCTGGAATG
HA012354-R ACTGCCAATGTGGCTGCTG 106
HSMPP8 HSMPP8.RT-2F AAAAGCACCTTGATGGGAAAGA
HSMPP8.RT-2R TTCACAGCATCCCTTAACACATTAC 79
(continued on next page)
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Table 3 (continued)
Gene Primer name Sequence (5′–3′) Product size (bp)
qPCR
ADRA1B ADRA1B.RT-2F GCATTGTGGTCGGTATGTTCAT
ADRA1B.RT-2R GGCTTCAGGGTGGAGAACAAG 85
bA16L21.2.1 BC048318.RT-2F GCCTACGAGACACTCAAGGATGA
BC048318.RT-2R AATGGCTGTAGTACTCTTCTGGATGA 82
336 E. Kitamura et al. / Genomics 89 (2007) 326–337that TDMs are cell type-specific events [20,23,39]. It will,
therefore, be important to determine the TDMs in specific cell
types that make up a particular tissue.
In this study, we analyzed only 14 TDMs in humans.
Additional analysis of the sequence and genomic features of
additional TDM regions should help to elucidate the critical roles
of DNA methylation in evolution, development, and disease.
Materials and methods
Human samples
Normal tissues were obtained from organ donation of autopsy cases after
receiving the informed, written consent of bereaved families or relatives at
Pathology Division, School of Medicine, Nihon University, Tokyo, Japan. The
samples were immediately frozen and stored at −80°C. At the same time, a part
of each sample was fixed and paraffin slides were prepared and stained by
routine hematoxylin and eosin (H&E) staining to observe pathological features.
Nine male autopsy cases, age 58–81 years (average 68 years old), were used in
this study. All experiments were conducted in accordance with the guidelines
approved by the Ethics Committee of Nihon University, School of Medicine.
Bisulfite sequencing
The METHPRIMER program (http://www.urogene.org/methprimer/index1.
html) [40] was used to design bisulfite PCR primers (Table 3). All primers were
purchased from Sigma Genosys. Genomic DNA from each sample was prepared
using QickGene-800 (FUJIFILM) and was subjected to bisulfite modification by
using the EZ DNA Methylation kit (Zymo Research). The bisulfite-treated
genomic DNAwas amplified by Taq DNA polymerase (Roche) (2 min at 94°C
followed by 40 cycles of 15 s at 94°C, 30 s at 50–60°C, and 30 s at 72°C with a
4-min final extension at 72°C) or AmpliTaq Gold (Applied Biosystems) (10 min
at 95°C followed by 40 cycles of 45 s at 95°C and 45 s at 50–60°C with a 10-
min final extension at 72°C) in a PTC-100 thermal cycler (MJ Research). The
PCR products obtained were cloned into pGEM-easy T vector (Promega) or
pCR2.1 TOPO vector (Invitrogen). Random white colonies were screened for
the correct-size insert in the plasmid by colony PCR. Twelve positive clones
were picked from each single bisulfite-treated DNA and the clones were
sequenced by the Dragon Genomics Center, Takarabio Inc. (Mie, Japan).
Southern blot analysis
The probe for hPvu6 (the USP49 gene) was prepared by PCR using the
primer sets as follows: USP49.probe-F, 5′-CAATGTTCCTTAGTCACGT-3′;
USP49.probe-R, 5′-TGGTGGCACACTCTAAGCA-3′ (product size: 553 bp).
Genomic DNA was double-digested with the combination of methylation-
sensitive enzyme NotI and methylation-insensitive enzyme EcoRI. The digested
DNA was separated by electrophoresis in 0.8% agarose gels and transferred to
Hybond-N+ membranes (GE Healthcare). The probe used for hybridization was
labeled with [α-32P]dCTP using MegaprimeTM DNA Labeling Systems (GE
Healthcare). The signals were detected and measured using FLA-5100
(FUJIFILM). The Image Plate method allowed the generation of PSL units as
an intensity of signals using MultiGauge software (FUJIFILM). PSL units were
background subtracted and then divided by square millimeters. This value is
designated (P−B)/mm2 andwas used for the analysis of the band signal intensity.Real-time quantitative RT-PCR
mRNA expression was analyzed by real-time RT-PCR. Total RNAs were
isolated from human tissues using TRIzol Reagent (Invitrogen) and then treated
with TURBO DNA-free (Ambion) to remove the contaminating genomic DNA.
Single-stranded cDNA was synthesized using a High-Capacity cDNA Archive
Kit (Applied Biosystems). The generated cDNAwas amplified on an ABI 7300
System (Applied Biosystems) using a Power SYBR Green PCR Master Mix
(Applied Biosystems) or SYBR Premix Ex Taq (TaKaRa Bio Inc.). The resulting
PCR cycle time (Ct) values were collected by using the software provided for the
ABI 7300 System and the data were analyzed using Microsoft EXCEL. The
expression level of the GAPDH gene was used to normalize for differences in
input cDNA. Primers were chosen from exons separated by introns except
ZNF324 and ZNF324B(FLJ45850) and the PCR quality and specificity were
verified by dissociation curve analysis and sequencing of the amplified products.
The primer sets used are shown in Table 3. Experiments were performed in
triplicate.
Sequence analysis
The database used for sequence analysis, BLAT, can be found on the UCSC
Genome Bioinformatics website (http://genome.brc.mcw.edu/). The mouse
TDM sequence is the sequence of a NotI–PvuII or NotI–PstI restriction
landmark fragment (6). The UCSC Genome Browser on Human, March 2006
assembly, was used for homology searches. The Primer 3 program (http://frodo.
wi.mit.edu/cgi-bin/primer3/primer3-www.cgi) and Primer Express (Applied
Biosystems) were used to design primers for RT-PCR.
Histological evaluation
A part of a normal tissue sample was subjected to paraffin slide preparation
and stained by routine H&E staining to observe pathological features.
Spermatocytes were counted from 30 seminiferous tubules from each testis by
the pathologist. The average number of spermatocytes per seminiferous tubule
was used to evaluate spermatogenesis.
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